L303-0825 Screening compound: N-cycloheptyl-1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide

L303-0825 Screening compound: N-cycloheptyl-1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide
L303-0825 Screening compound: N-cycloheptyl-1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L303-0825
N-cycloheptyl-1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L303-0825

Molecular Formula

C24H32N4O4S (C24 H32 N4 O4 S)

Compound Name

N-cycloheptyl-1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide

IUPAC name

N-cycloheptyl-1-[4-(5-cyclopropyl-124-oxadiazol-3-yl)benzenesulfonyl]piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1S(c(cc1)ccc1-c1noc(C2CC2)n1)(=O)=O)NC1CCCCCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

472.61

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.825

Distribution Coefficient, logD

4.825

Water Solubility, LogSw

-4.68

Polar Surface Area

88.348

Acid Dissociation Constant (pKa)

14.37

Base Dissociation Constant (pKb)

1.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

62.50

L303-0825 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L303-0825 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L303-0825?
Check Price and Availability of L303-0825, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L303-0825 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L303-0825
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L303-0825
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L303-0825 available by request